Saturday, November 7, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

HHS won't act against pharmacies making 6 unapproved peptides | Tap to know more | Inshorts

The US' health department, HHS, has said it will not take enforcement action against licensed pharmacies and physicians compounding six unapproved peptides, including BPC157 and…

DO
By Daniel Okafor · Regulatory Correspondent
Nov 6 20:10 ETSource: Inshorts

From the source

HHS won't act against pharmacies making 6 unapproved peptides | Tap to know more | Inshorts

The US' health department, HHS, has said it will not take enforcement action against licensed pharmacies and physicians compounding six unapproved peptides, including BPC157 and TB500. An FDA advisory panel backed the peptides in July, though FDA staff had recommended against it. The department said compounded drugs are not FDAapproved and the policy is interim.

Read at inshorts.com
PeptiPrescribed peptides from $99/moSee all →